The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2019Astrocyte Activation as a Novel Marker of Disease Progression in Parkinson’s Disease: A PET Imaging Study
Study Rationale:
Brain inflammation, regulated by cells called microglia and astrocytes, has been shown to play a role in the initiation and progression of Parkinson’s disease. However, the role of... -
LRRK2 Biology Consortium, 2019LRRK2 Activity and Dyskinesia Supplement
Promising Outcomes of Original Grant:
Our preliminary funding supported exploration of the role of striatal LRRK2 in the development of levodopa-induced dyskinesia (LID). We found that inhibiting... -
Epidemiological Parkinson's Risk Modifiers, 2019Study in French Population to Identify Therapies with Repurposing Potential for Parkinson’s Disease
Study Rationale:
There is an urgent need to identify effective, safe and inexpensive drugs for Parkinson’s disease, and over past years, there has been increasing interest on ways to repurpose... -
Research Grant, 2019Alpha-Synuclein PET Imaging Tracer Development
Study Rationale:
Alpha-synuclein is a protein that aggregates in several brain diseases, including Parkinson’s, dementia with Lewy bodies and multiple system atrophy. There is no established method... -
Target Advancement Program, 2019Analysis and Amplification of Pathological Alpha-synuclein from Brain Tissue
Study Rationale:
Parkinson’s disease is characterized by the misfolding and accumulation of the alpha-synuclein protein in the brain. Therefore, alpha-synuclein-based disease... -
Target Advancement Program, 2019GBA Stabilization through Nanobodies
Study Rationale:
Mutations in the GBA gene are a known genetic risk factor for Parkinson’s disease and cause reduced stability and activity of the GBA protein. This can contribute to the impairment of...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.